Trusted Resources: News & Meetings
Latest announcements and gatherings
Luna and Partners Work to Accelerate Therapies for Hunter Syndrome
Advocacy organizations—the National MPS Society and Genetic Alliance—partnered with Luna to achieve this goal. In early December, we started enrolling participants in a health information-sharing and medical-discovery digital community that begins in the homes of families living with Hunter syndrome. The program is called 100 Patient Project: Unlocking MPS.
This program demonstrates a study framework where all parties are better served while enhancing research goals. This design ensures the clinical and behavioral features and key endpoints are incorporated into the drug discovery process. This can only happen when families—those who live daily with the disease and know the lived experience best—have a seat at the table as partners.
BookmarkRelated Content
-
Expanding the Phenotype of Mucopolysaccharidosis Type II RetinopathyPurpose: To report novel retinal finding...
-
Bob StevensBob Stevens is Group Chief Executive Off...
-
A 1-Year and 4-Month-Old Child With Mucopolysaccharidoses Type II: A Clinical Case Report From EthiopiaMucopolysaccharidoses (MPSs) are a class...
-
Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities fo...Mucopolysaccharidosis type II (MPS II) r...
-
Impact of the COVID-19 Pandemic on the Standard of Care for Patients With Lysosomal Storage Diseases: A Survey of He...The impact of the COVID-19 pandemic on t...
-
Cure Sanfilippo Foundation – InstagramCure Sanfilippo Foundation is a non prof...
-
Terri L. Klein Received the WORLDSymposium 2021 Patient Advocate Leader (PAL) AwardTerri is a founding member of the Mucoli...
Powered by
